Washington University Pathology Services is a leader in ancillary testing and we focus on bringing personalized medicine through the delivery of precise diagnostic results. Our faculty members have a range of subspecialty expertise and our accurate diagnoses provide physicians and patients with the tools to find the best treatment options available.

Find out about our latest advancements in testing initatives below.


ChomoSeq is an advanced diagnostic assay based on whole genome sequencing (WGS) that is intended to provide a comprehensive genomic assessment of newly diagnosed patients with myeloid malignancies (AML and MDS). Find out more about this test here.


A targeted sequencing assay for 40 genes and gene hotspots that are recurrently mutated in acute myeloid leukemia and myelodysplastic syndrome using UMI- based targeted sequencing approach. Order the test here.